Web Desc
Antibodies as Drugs
joint with Computational Design and Modeling of Biomolecules
Scientific Organizers: Pierre Bruhns, Esther Breij and David P. Humphreys
Date: January 30 - February 02, 2022
InPerson Location: Keystone Resort, Keystone, CO, USA
Meeting is available as a Livestream, click register button below for more details
Meeting is available to view On Demand, click register button below for more details
Sponsored by Biogen, Genentech, Inc., Genmab A/S, Incyte Corporation and Regeneron Pharmaceuticals, Inc.
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Summary of Meeting:
Therapeutic antibodies continue to largely populate the list of top biologic drugs. They revolutionize the treatment of pathologies falling into major disease areas, which include cancer, chronic inflammatory diseases, allergy and infectious diseases. As more antibodies are being tested to treat an expanding number of pathologies, there has also been a concomitant increase in the frequency of resistance and escape mechanisms. Thus, researchers are exploring alternative concepts to prevent unresponsiveness or treat resistant patients. Therefore, not only are new methodological and technological advances being developed, paradigm-shifting concepts are being developed in order to face these challenges. This conference in the Keystone Symposia series on Antibodies as Drugs aims to present the state-of-the-art in antibody therapeutics, repertoires and deep learning, bispecific antibodies and engineering. This conference will provide a forum for extensive interactions between investigators from both industry and academia. Goals of this conference include discussion of recent breakthroughs in identifying therapeutics from patients, understanding vaccination and mode of delivery, modalities for half-life extensions and involvement of complement in antibody mode of action. It is anticipated that research in the field will showcase the rise of bispecific antibodies and highlight the technologies to develop them, improve their functionalities, and boost clinical efficacies, particularly in immune-oncology.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Award Deadline: January 10 2022 details
Scholarship Deadline: October 14 2021 details
Abstract Deadline: October 21 2021 details & pricing
Discounted Registration Deadline: November 30 2021 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.


IT'S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received may still be considered for a short talk if space is available. We will accept abstracts for poster acceptance until 2 weeks prior to the meeting start date.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BiogenGenentech, Inc.Genmab A/SIncyte CorporationRegeneron Pharmaceuticals, Inc.
We gratefully acknowledge additional support for this conference from:
Alloy Therapeutics, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI154980-01
Funding for this conference was made possible (in part) by 1R13AI154980-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found